CD5 and marginal zone lymphoma: In 2010 our group described an entity presenting with bone marrow infiltration and blood involvement by CD5(−) lymphocytes of marginal zone origin without any other disease localization, which was named primary bone marrow MZL (PBMMZL) [61].